PAI
AGN

Palo Alto Investors’s Allergan Inc AGN Stock Holding History

Palo Alto Investors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-73,900
Closed -$12.5M – 46
2014
Q2 		$12.5M Buy
+73,900
New +$11.5M 0.93% 28

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Palo Alto Investors's AGN Position: Q3 2014 in Review

Palo Alto Investors sold out of Allergan Inc (AGN) in Q3 2014, closing a stake of 73,900 shares — an estimated $12.5M sold.

Palo Alto Investors first reported a position in AGN in Q2 2014 and held it in 1 quarter. The position peaked at $12.5M in Q2 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Palo Alto Investors reported no remaining Allergan Inc position as of Q3 2014 after selling out during the quarter.
  • Palo Alto Investors sold 73,900 Allergan Inc shares in Q3 2014, an estimated $12.5M.
  • Palo Alto Investors first reported a position in Allergan Inc in Q2 2014 and held it in 1 quarter.
  • Palo Alto Investors's Allergan Inc position peaked at $12.5M in Q2 2014.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on Palo Alto Investors's 13F filing for Q3 2014, filed 13 Nov 2014.